Funding

#Artificial intelligence (AI) #Funding #Mouse models #PhaSER Biomedical (PhaSER)

 PhaSER receives $2.7 million to grow company

Biotechnology company PhaSER Biomedical has received $2.7 million from the Gates Foundation as part of a two-year grant renewal.  The Scottish-based company will use the funding to support the discovery of new treatments targeting some of the world’s most neglected diseases.   The funding continues PhaSER’s role as a collaborator in… Read More

#Business & Investment #News

#Biotech #Drug discovery #Funding #Investment

3 key takes from Optimum’s Investor Conference

DDW Editor Reece Armstrong offers three key takeaways from Optimum's Annual Healthcare Investor Conference.  AI is still dominating the conversation AI was an obvious talking point throughout the conference, with its application in both investing and in drug discovery and development being major points of discussion. As someone who regularly… Read More

#Exclusive Content

Sleep study in older man
#AstronauTx #Funding #Neuroscience #Parkinson's

Grants support research into sleep mechanisms in Parkinson’s

AstronauTx has received funding from The Michael J Fox Foundation for Parkinson’s Research (MJFF), while Parkinson’s UK is funding an additional complementary research effort in collaboration with University College London (UCL).  The MJFF-funded project, titled ‘Ligand-Gated Ion Channel Modulation as a Disease-Modifying Treatment for Prodromal Synucleinopathies’, will… Read More

#News

A member of staff at the Edinburgh Genome Foundry
#Artificial intelligence (AI) #Edinburgh Innovations #Funding #Genetics / genomics #The Advanced Research and Invention Agency (ARIA)

Funding boost transforms AI-enabled biological innovation

The Edinburgh Genome Foundry (EGF), one of the world’s leading bio-foundries, is collaborating with The Advanced Research and Invention Agency (ARIA) to accelerate biological research and unlock new discoveries that benefit everyone.  The three-year programme will provide ARIA with access to and expansion of EGF’s automated laboratory… Read More

#News

Chemistry
#Artificial intelligence (AI) #Deep tech #Funding #Molecular medicine #Spinout #University of Glasgow

Scottish deep-tech company secures £22 million in grants

Scottish deep-tech company Chemify has received £22 million ($29.7 million) in grants from Scottish Enterprise and the UK Government.   The funding will support a significant expansion of Chemify’s capacity to digitise molecular discovery, synthesis and scale-up through a new Chemifarm.  The grant package includes £16 million ($21.6 million) from Scottish… Read More

#Business & Investment #News

US science protest
#Drug discovery #Funding #National Institutes of Health (NIH) #Politics #United States

Researchers challenge NIH screening of scientific research grants

US researchers have filed a class action lawsuit challenging the National Institutes of Health’s (NIH) policy of blocking grants to censor views it disagrees with, on everything from DEI to gender identity to climate change.  The plaintiffs are represented by the American Civil Liberties Union, the ACLU… Read More

#Editor's Choice #News #Trending News

#CONNECTA Therapeutics #Funding #Phase II trial #Rare disease

€3.1 million to support Fragile X syndrome programme

CONNECTA Therapeutics has closed a €3.1 million financing led by new investor Clave Capital through its Innvierte Science Tech Clave Innohealth, FCR fund.  The funds will support CONNECTA in accelerating the Phase IIa clinical trial of CTH120 in adult males with Fragile X syndrome (FXS).  Jordi Fàbrega, Co‑Founder and CEO… Read More

#Business & Investment #News

AI and genomics
#Artificial intelligence (AI) #Funding #Genomics #Innovate UK #OutSee

OutSee receives Innovate UK grant for agentic AI pilot study

Genomics drug discovery company OutSee has been awarded funding through Innovate UK’s Investor Partnership Grant, jointly provided by Innovate UK and Empirical Ventures.   The grant will enable OutSee to conduct a pilot study for a prototype target validation sub-system, designed for initial triage of potential drug targets… Read More

#News

#BioInnovation Institute #Drug discovery #Funding #Investment

BII allocates eight million euros to three drug discovery companies

Six promising companies will receive additional funding of €1.3 ($1.5) million each from BioInnovation Institute (BII) to help them bring their technologies and products closer to market.  The six companies – PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava – have all previously received €0.5 million in funding… Read More

#Business & Investment #News

Tau proteins
#Alzheimer's #Funding #Neurodegenerative disorders #Neuroscience

Four scientists awarded $3m for tau-driven disease research

A group of charities have announced $3 million in grants to fund four innovative research projects over two years, stemming from the 2026 Tauopathy Challenge Workshop.   The Rainwater Charitable Foundation, in collaboration with the Alzheimer’s Association, the Aging Mind Foundation, and CurePSP, will fund the proposals based… Read More

#News

Pancreatic cells
#Funding #Oncology #Pancreatic cancer

$6.7m awarded to pancreatic cancer research projects

The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) is awarding $6.7 million to eight projects in 2026.  The funded projects span the full continuum of pancreatic cancer research, from prevention and early detection to next-generation therapies.   “Every investment we make is driven by one goal:… Read More

#Cancer Research #News

Human kidneys
#Biotechnology #Clinical stage biotechnology #Drug discovery #Funding #Rege Nephro #Regenerative Medicine

Rege Nephro secures US$10.6m for ADPKD and beyond

Rege Nephro, a Japanese clinical-stage biotechnology company focused on iPS cell-based kidney regenerative medicine and drug discovery, has closed a financing round totalling approximately US$10.6 million. Through the issuance of Japan-Keep It Simple Security (J-KISS) share acquisition rights, proceeds are expected to support commercialisation activities for RN-014, the company’s lead… Read More

#News

#Cancer research #Clinical trial #Drug discovery #Francis Crick Institute #Funding #Genetic profiling #GLP-1 #Lung cancer #MHRA #National Institute for Health and Care Research #Obesity #Oncology #Rare disease #Regulatory #The Royal Marsden NHS Foundation Trust #University College London #Weight loss

DDW Highlights: 16 June 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, new research showed anti-IL-1β drugs could prevent lung cancer. Elsewhere, the… Read More

#Podcasts

#Cancer research #Clinical trial #Drug discovery #Funding #Genetic profiling #GLP-1 #Lung cancer #MHRA #National Institute for Health and Care Research #Obesity #Oncology #Rare disease #Regulatory #The Francis Crick Institute #The Royal Marsden NHS Foundation Trust #University College London #Weight loss

This week in Drug Discovery (8 – 12 June) 

News round-up for 8 – 12 June by Bruno Quinney, Content Team at DDW.  This week, new research suggests anti-IL-1β drugs could prevent lung cancer. Elsewhere, the UK is set to benefit from specialised blood tests and funding for researchers.   The top stories:   … Read More

#News

Two scientists working in a research laboratory
#Career #Drug discovery #Funding #National Institute for Health and Care Research

Over £37m funding to boost early career researchers in the UK

The National Institute for Health and Care Research (NIHR) is awarding £37 ($49) million in funding to medical research charities to support early career researchers.  It is hoped that the scheme, in partnership with the Association of Medical Research Charities (AMRC), will help medical research charities continue… Read More

#News

#Financing #Funding #Immune system #IMU Biosciences

IMU Biosciences raises $53m to expand disease platform

IMU Biosciences has raised $53 million in a Series A financing round, pledging to use the funds to change understanding, diagnosis and treatment of disease. The biotechnology company has built what it claims to be the world’s largest immune dataset, scaling to more than 25,000 individuals in 2026 through access… Read More

#Business & Investment #News